Metronomic chemotherapy and breast cancer
10.3760/cma.j.issn.1673-422X.2011.07.014
- VernacularTitle:节律化疗与乳腺癌
- Author:
Lili SHI
;
Lin MOU
;
Li LI
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Angiogenesis inhibitors;
Metronomic chemotherapy
- From:
Journal of International Oncology
2011;38(7):524-527
- CountryChina
- Language:Chinese
-
Abstract:
Angiogenesis plays a very important role in the development and metastasis of breast cancer. Low-dose metronomic chemotherapy based on the traditional chemotherapy drugs has antiangiogenic effect. As far as its mechanism, low toxicity or low incidence of drug resistance is concerned, it is feasible for breast cancer therapy. It displayed the validity and feasibility in the pre-clinical studies and clinical trials, which provided a new treatment strategy for the breast cancer.
